Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B
Protein Science · 2025-12 · 34 (12)
DOI: 10.1002/pro.70365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, online erschienen am 13.11.2025. Verfasst von Jade M Katinas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Carrier Proteins, Cell Cycle Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Arvinas, Inc, NIGMS NIH HHS.
Abstract (Originalsprache)
Targeted protein degradation using PROTACs (PROteolysis TArgeting Chimeras) has emerged as a transformative therapeutic strategy, largely relying on a small number of E3 ubiquitin ligases such as CRBN and VHL. However, resistance, toxicity, and poor oral bioavailability limit the utility of PROTACs and highlight the need to expand the E3 ligase toolbox. Fem‐1 homolog B (FEM1B) is a lesser‐known E3 ligase that offers a promising alternative due to its broad expression and ability to recognize diverse degron motifs. Here, we describe the development of a stable construct of FEM1B, the results of a protein‐observed NMR‐based fragment screen using this construct, and the X‐ray structures of some of the fragment hits when bound to the protein. From these results, new PROTACs utilizing FEM1B as the E3 ligase may be discovered, providing an alternative E3 ligase for targeted protein degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
- Arvinas, Inc., New Haven, Connecticut, USA.
- Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
- Department of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.
ORCID-Profile: Jade M Katinas
Förderung
- NIH HHS
- Arvinas, Inc
- NIGMS NIH HHS
- NCRR NIH HHS
Zitieren
APA
Katinas, J. M., Amporndanai, K., Taylor, A. J., Rose, K. L., Gareiss, P. C., Crespo, R. A., Phan, J., Waterson, A. G., & Fesik, S. W. (2025). Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B. Protein Science, 34(12). https://doi.org/10.1002/pro.70365
Vancouver
Katinas JM, Amporndanai K, Taylor AJ, Rose KL, Gareiss PC, Crespo RA, et al. Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B. Protein Science. 2025;34(12). doi:10.1002/pro.70365
BibTeX
@article{Katinas2025,
author = {Katinas, Jade M and Amporndanai, Kangsa and Taylor, Ashley J and Rose, Kristie L and Gareiss, Peter C and Crespo, Roberto A and Phan, Jason and Waterson, Alex G and Fesik, Stephen W},
title = {Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B},
journal = {Protein Science},
year = {2025},
volume = {34},
number = {12},
doi = {10.1002/pro.70365}
}
EUVIMED